Multicentric, surveillance study to monitor safety and reactogenicity of GSK Biologicals' purified meningococcal polysaccharide vaccine of serogroups ACWY in 3,000 Filipino subjects aged greater than 2 years when administered according to the prescribing information.

Trial Profile

Multicentric, surveillance study to monitor safety and reactogenicity of GSK Biologicals' purified meningococcal polysaccharide vaccine of serogroups ACWY in 3,000 Filipino subjects aged greater than 2 years when administered according to the prescribing information.

Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Mar 2017

At a glance

  • Drugs Meningococcal vaccine groups A C Y W-135 polysaccharide (Primary)
  • Indications Meningococcal infections
  • Focus Adverse reactions; Registrational
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 02 Nov 2008 Actual patient number (249) added as reported by ClinicalTrials.gov.
    • 17 Jul 2008 GlaxoSmithKline Biologicals reported as trial affliate by ClinicalTrials.gov.
    • 17 Jul 2008 The expected completion date for this trial is added (Oct 2006) as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top